Biohit Oyj operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Biohit Oyj with three other
pharmaceutical manufacturers in Europe:
sales of 2.08 million Euro [US$2.27 million]
of which 75%
was Product sales (own and third party)),
(33.86 million Swedish Kronor [US$3.79 million]
IDL Biotech AB
based in Sweden
(28.52 million Swedish Kronor [US$3.19 million]
Biohit Oyj reported sales of 6.05 million Euro (US$6.59 million)
December of 2015.
increase of 38.7%
versus 2014, when the company's sales were 4.36 million Euro.
This was the third consecutive year of growth at Biohit Oyj.